35th Annual General Meeting is scheduled on Friday, August 14, 2026 at 12:15 HRS IST.
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Strides Pharma Science has announced its 35th AGM on August 14, 2026, at 12:15 hrs IST, to be held via video conferencing. Shareholders will vote on adopting the FY26 audited financial statements, declaring a final dividend of Rs. 5 per equity share (face value Rs. 10), and the record date for the dividend is July 31, 2026. Three director-related items are on the agenda: re-appointment of founder Arun Kumar (who retires by rotation), appointment of his son Aditya Arun Kumar as a Non-Executive Director (transitioning from his previous Executive Director role), and appointment of Venkata Seetharama Raju Pakalapati (Ram) as Executive Director for three years with a total annual remuneration of Rs. 5.04 crore. The company is also seeking shareholder approval to pay up to Rs. 50 lakh per Non-Executive Director as commission in years with inadequate profits, valid for three years from FY27.
The Rs. 5 per share final dividend rewards shareholders, while the leadership changes signal continued professionalization of management with Ramaraju, an internal COO, stepping up as Executive Director. The higher commission cap for non-executive directors reflects expanded roles but is contingent on shareholder approval.